This company listing is no longer active
HEXO Stock Overview
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
HEXO Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.71 |
| 52 Week High | CA$3.84 |
| 52 Week Low | CA$0.66 |
| Beta | 2.13 |
| 1 Month Change | -42.74% |
| 3 Month Change | -45.38% |
| 1 Year Change | -78.85% |
| 3 Year Change | -98.17% |
| 5 Year Change | -99.68% |
| Change since IPO | -99.15% |
Recent News & Updates
Recent updates
Hexo to produce Mike Tyson's cannabis brand's products in Canada
Aug 30Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatter
Aug 17HEXO receives additional 180 calendar day grace period for regaining compliance
Jul 28HEXO wins shareholder approval for note transaction with Tilray
Jul 05HEXO: Undervalued, But With Certain Dilution Risks
Apr 28HEXO Q1 Earnings: Not A Great Path Forward
Dec 14Shareholder Returns
| HEXO | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -5.3% | -0.6% | 1.0% |
| 1Y | -78.9% | 10.6% | 21.9% |
Return vs Industry: HEXO underperformed the US Pharmaceuticals industry which returned -1.9% over the past year.
Return vs Market: HEXO underperformed the US Market which returned 9.1% over the past year.
Price Volatility
| HEXO volatility | |
|---|---|
| HEXO Average Weekly Movement | 15.2% |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HEXO's share price has been volatile over the past 3 months.
Volatility Over Time: HEXO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Charlie Bowman | www.hexocorp.com |
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names.
HEXO Corp. Fundamentals Summary
| HEXO fundamental statistics | |
|---|---|
| Market cap | US$30.45m |
| Earnings (TTM) | -US$207.74m |
| Revenue (TTM) | US$94.37m |
0.3x
P/S Ratio-0.1x
P/E RatioIs HEXO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEXO income statement (TTM) | |
|---|---|
| Revenue | CA$124.10m |
| Cost of Revenue | CA$192.65m |
| Gross Profit | -CA$68.55m |
| Other Expenses | CA$204.64m |
| Earnings | -CA$273.18m |
Last Reported Earnings
Apr 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.21 |
| Gross Margin | -55.23% |
| Net Profit Margin | -220.13% |
| Debt/Equity Ratio | 124.7% |
How did HEXO perform over the long term?
See historical performance and comparison